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Introduction
Neuroactive steroids are among the most potent and efficacious potentiators of the GABA-A receptor. They interact with portions of the receptor embedded in the plasma membrane (Akk et al., 2005) , as might be expected for hydrophobic compounds. A series of experiments have supported the idea that there is more than one steroid-binding site involved in producing potentiation, which recognize specific features of the steroid molecule (Akk et al., 2004; Akk et al., 2008; Li et al., 2007a) . However, a recent study found that mutation of a single residue in the α 1 subunit can reduce or remove potentiation and concluded that a single site is required for potentiation (Hosie et al., 2006) . There are two copies of the α subunit in each pentameric GABA-A receptor, raising the possibility that the sites may mediate distinguishable effects based on the position of the subunit in the receptor. To examine this question, we used concatemers of subunits (Baumann et al., 2001; Baumann et al., 2003; Im et al., 1995) , in which the two α 1 subunits could be separately mutated and the consequences examined. We constructed two concatemers, one comprising β 2-α1 subunits (amino-to carboxy-termini), and the other γ 2L-β2-α1.
To examine the role of the sites, we used two mutations. The first was α 1 Q241L.
Previous work using free subunits has indicated that this mutation removes potentiation by preventing the effects of steroids on single channel currents (Akk et al., 2008) . The concentration of GABA producing a half maximal response is also increased (Akk et al., 2008; Hosie et al., 2006) . The second was α 1 Q241W. In this case, steroid potentiation is also lost (Akk et al., 2008; Hosie et al., 2006) but in records of single channel currents the mutation mimics the presence of a bound steroid (Akk et al., 2008) . The concentration of GABA producing a half maximal response is decreased (Akk et al., 2008; Hosie et al., 2006) . In addition, the α 1 Q241W mutation enhances activation by the partial agonist P4S (Akk et al., 2008; Hosie et al., 2006) . Accordingly, study of the α 1 Q241W mutation allowed us to examine the acquisition of a steroid-mediated effect, as well as the loss of one. To examine the actions of neurosteroids, we used both a 5α-reduced steroid and a 5β-reduced steroid.
Our results indicate that the presence of a single wild-type site in the GABA-A receptor can support the actions of a steroid, assayed at the level of macroscopic responses. When the α 1 Q241L mutation was examined, mutation of the subunits were mutated. When the α 1 Q241W mutation was made, mutation of the α 1 subunit in either concatemer produced a partial effect. Accordingly, it appears that both α 1 subunits contribute to the actions of steroids. Either mutation, when placed in a single α 1 subunit, had similar relative effects on activation by GABA and P4S and potentiation by a 5α-and a 5β-reduced steroid. Thus, the sites did not appear to differ in terms of their efficacy at producing one or another effect of steroids.
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Materials and methods
Concatemers were generated which were identical in sequence to those described by Bauman et al (2002) . We first generated the β 2-α1 concatemer having a linker with 23 amino acid residues: Q 3 (Q 2 A 3 PA) 2 AQ 5, with a FLAG tag on the N-terminus of the β 2 subunit between residues 4 and 5 of the mature peptide. The subunits were joined together with the linker through site directed mutagenesis by overlap extension (Ho et al., 1989) and subcloned into pcDNA3. The γ2L-β2-α1 tandem was also generated by overlap extension, joining the γ and β subunits together with the 26 amino acid residue sequence Q 5 A 3 PAQ 2 (QA) 2 A 2 PA 2 Q 5. The resulting PCR product was subcloned into the Antonio) were used. Concatemers were generated in pcDNA3 (Invitrogen, Carlsbad, CA) , and the full length of the insert was sequenced. RNA was produced using mMessage mMachine (Ambion, Austin TX). RNA was diluted in de-ionized water at a 1:1 ratio for the concatemers, and for most constructs 2.3 ng (total DNA) in a volume of 23 nL was injected in each oocyte.
Oocytes were incubated at 18 o C for 1 to 3 days after injection.
We did not assay the expression levels for the constructs, but in terms of the response to 1 mM GABA it appeared that when either mutation is in a single concatemer surface expression is not reduced from wild-type levels (data not shown). When either mutation is present in both concatemers expression is reduced, particularly for the α 1 Q241L mutation.
Accordingly, when both concatemers contained the Q241L mutation a total of 23 ng was injected in a volume of 23 nL.The α 1 Q241L mutation greatly reduced expression of free subunits in HEK cells, whereas the Q241W mutation had lesser effects (Hosie et al., 2006) .
Two electrode voltage clamp, drug application and data acquisition have been described earlier (see Li et al., 2007b; McCann et al., 2006) . The peak response was obtained from an average over an interval centered at the maximal response and corrected by subtracting the mean baseline preceding the drug application. The effects of steroids were tested by coapplication with agonist, without pre-application of steroid alone. Initially the concentrationresponse relationship for GABA was obtained for each combination of concatemers in a group of oocytes, and used to estimate a concentration of GABA which would produce a response of 5% to 10% of the maximal response. Potentiation was assessed from the peak response to GABA plus steroid divided by the peak response to that concentration of GABA alone for that oocyte. The concentration-effect relationship for GABA was normalized to the response of that oocyte to 1 mM GABA.
The amount of potentiation is strongly dependent on the level of activation produced by the given concentration of GABA alone (see Results). Because there is some variability among oocytes in the concentration-response relationship for GABA, each oocyte was tested with 1 mM GABA and other responses normalized to that. The responses to GABA alone were then corrected to the fraction of maximal response using the average fitted maximal response relative to 1 mM GABA determined from the GABA concentration-response relationships for that particular pair of concatemers (see Results). Data were not used if a response was less than 10 nA, because variability could result in large effects on calculated ratios.
Data were subsequently analyzed using pClamp, Excel (Microsoft, Redmond WA) and
SigmaPlot and Systat (Systat Software, San Jose CA). Values are shown as mean ± SE (number of experiments).
Analysis of the relationship between potentiation and activation
As described in Results the amount of potentiation is dependent on the activation of the receptor. We have used a simple model to allow analysis of all of the data on potentiation. This model relates potentiation to activation, independent of the concentration or nature of agonist.
We neglect the complexities of the gating of GABA receptors and assume that the receptor has either an open or a closed channel. The theoretical fractional activation for a given control response (X) is
where k open, X is the effective opening rate and k close, X is the effective closing rate for that particular control response (indicated by X). An important point is that the theoretical fractional activation is not identical to our experimental fraction activation. The theoretical fractional activation has a maximal value which can be less than 1, whereas the experimental value is defined to be 1 at the observed maximal response. For the wild-type GABA-A receptor, the maximal probability of being open is about 0.8 (Steinbach and Akk, 2001 ). This value is likely somewhat reduced for receptors containing the α 1 Q241L mutation and increased for the α 1 Q241W mutation (Akk et al., 2008) analysis, the maximal probability of being open is assumed to be the same for all constructs and equal to 1, and the experimental estimates have not been corrected.
To incorporate potentiation, we begin with the previous finding that potentiation of responses to GABA results from a reduction in the channel closing rate, with no change in the opening rate (Akk et al, 2004) . Accordingly, for a given concentration of potentiator the response in the presence of potentiator is
where Z is a factor (0<=Z<=1) indicating how much the effective closing rate is decreased. The ratio of the potentiated to the control response (the "potentiation ratio" plotted in the Figures 
P(X) = 1/(1 + ZL(X)) and
The inverse of the potentiation ratio is, then,
Thus, a plot of 1/PR(X) against F(X) will result in a straight line with slope (1-Z) and intercept Z.
In this very simple model, a single parameter (Z) is used to describe the relationship between potentiation and control activation. Again, note that as a result of the assumptions 0<=Z<=1. Furthermore, for a control response producing a very small fractional activation L(X) >> 1, so the potentiation ratio is approximately L(X) / ZL(X), or 1/Z.
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Results
Choice of mutations
The α 1 Q241L and Q241W mutations were selected because they have different effects on steroid potentiation. Both essentially remove potentiation by neurosteroids (Akk et al., 2008; Hosie et al., 2006) . In studies of single channel currents Q241L prevents the kinetic changes produced by steroids (Akk et al., 2008) . In contrast, Q241W mimics the kinetic changes produced by steroids and prevents additional potentiation (Akk et al., 2008) . The Q241L mutation shifts the EC 50 for activation by GABA to higher concentrations, likely as a result of decreased mean open duration (Akk et al., 2008) . Q241W shifts the EC 50 for activation by GABA to lower concentrations, likely as a result of increased mean open duration (Akk et al., 2008) . The effects of Q241L on activation by P4S have not been studied, but Q241W enhances activation in single channel currents (Akk et al., 2008) and increases the maximal response to P4S relative to the maximal GABA response (Hosie et al., 2006) . Based on these considerations, it appeared that it would be possible to compare consequences of mutations which had qualitatively opposite effects.
The role of the α 1 Q241 residue is not completely clear. Recent studies have indicated that this residue may not solely provide a binding site for steroids, but may also be important for shaping the structure of the first transmembrane helix of the subunit (Akk et al., 2008) .
Concatemers containing wild-type α 1 subunits
The structure of the concatemers is summarized in Figure 1 , with the structures of the steroids tested. Traces of representative recordings from oocytes are shown in Supplemental Table 1 .
One μ M 3α5αPOH ((3α,5α)-3,21-dihydroxypregnan-20-one) potentiates responses to low concentrations of GABA quite effectively ( Figure 3A ). The data in Figure 3A show the potentiation ratio (defined as the ratio of the response to a given [GABA] in the presence of This article has not been copyedited and formatted. The final version may differ from this version. Table 2 ). Because of some variability in the concentration-response curves for GABA among oocytes, the data will be presented in terms of control fractional activation, rather than the [GABA] used to elicit the response. On average, for control responses producing less than 0.11 of the maximal response, 1 μ M 3α5αPOH increases the response by 6.3 ± 0.5 fold (Table 3) .
Similar results were obtained with a second potentiating steroid, 3α5αP ((3α,5α)-3-hydroxypregnan-20-one, allopregnanolone) and a 5β-reduced steroid, 3α5βPOH ((3α,5β)-3,21-dihydroxypregnan-20-one) ( Figure 3B ; mean values in Table 3 ).
The partial agonist P4S was tested only at a high concentration, 1 mM, which should produce a maximal, albeit small, response (Ebert et al., 1994) . As summarized in Table 1, P4S elicits a small maximal response. One μ M 3α5αPOH potentiates the responses to 1 mM P4S ( Figure 3C , Table 2 ). This contrasts to the observation that 3α5αPOH does not potentiate the responses to 1 mM GABA (Table 2) . This difference is expected, and reflects the fact that P4S
produces a low maximal probability of being open (Steinbach and Akk, 2001) . It is interesting that the data for P4S and for GABA superimpose when potentiation is plotted as a function of control fractional activation ( Figure 3C ).
Concatemers containing α 1 subunits with the Q241L mutation
The consequences of the α 1 Q241L mutation in individual subunits were examined using two concatemers, which will be abbreviated as γ β α 
When both concatemers contain the mutation, the EC 50 for activation by GABA is increased about 2.8-fold ( Figure 2 , Table 1 ). The effect of placing the mutation solely in the γ β α (Q241L) concatemer is very small. The effect is larger when the mutation is only in β α concatemers produces a partial reduction ( Figure 4 and Table 3 ). Clearly, potentiation can be mediated by a wild-type site in either
P4S is an inefficacious agonist for concatemers containing the α 1 Q241L mutation (Table 1) , as for the wild-type concatemers. To discount the possibility that the mutation shifted the EC 50 so that 1 mM P4S is no longer saturating, we tested the response to 10 mM P4S of one oocyte injected with the γ β α (Q241L)-βα(Q241L) combination. The response was about 1.2-fold times the response to 1mM P4S. This observation suggests that no major shift occurred, and that 1 mM P4S is still saturating for activation.
However, 3α5αPOH no longer potentiates the response to 1 mM P4S when both concatemers contain the mutation (Table 2 ). When only a single Table 2 ).
Concatemers containing α 1 subunits with the Q241W mutation
In contrast to the α 1 Q241L mutation, the α 1 Q241W mutation appears to occlude potentiation by mimicking a bound steroid molecule (Akk et al., 2008) . We tested the possible combinations of concatemers containing the
When both concatemers contain the mutation, the EC 50 for GABA is decreased by about 3.7-fold ( Figure 2 , Table 1 ). Placing the mutation solely in a single concatemer shifts the EC 50 in the same direction, but to a lesser extent.
Potentiation by 1 μ M 3α5αPOH and 3α5βPOH is abolished when the mutation is present in both concatemers ( Figure 5A , Table 3 in potentiation. In the case of this mutation the reduction is similar for either single mutation.
However, again potentiation can be mediated by a wild-type site in either
The agonist efficacy of P4S is greatly increased by the presence of the
This article has not been copyedited and formatted. The final version may differ from this version. mutation in both concatemers (Table 1) , and 3α5αPOH no longer potentiates the response to 1 mM P4S ( Figure 5B , Table 2 ). Because the response to 1 mM P4S is increased so much when the α 1 Q241W mutation is in both concatemers, we also tested potentiation of responses to 10 μ M P4S. In this case, the control response as a fraction of maximal response is only 0.04 ± 0.00 (3 oocytes), while potentiation is still absent (1.04 ± 0.06). When the mutation is present in a single subunit the relative response to 1 mM P4S is increased but not as much as when the mutation is present in both (Table 1) . As is seen for potentiation by GABA, potentiation of responses to 1 mM P4S is reduced but not completely lost when only a single α 1 subunit is mutated ( Figure 5 , Table 3 ), and the reduction is more marked when the mutation is the in β α (Q241W) concatemer.
Analysis of the relationship between potentiation and activation
At present, our understanding of the kinetic mechanisms for either activation or potentiation of the GABA-A receptor is too incomplete to allow a full analysis of the relationship between potentiation and activation. However, it is highly desirable to have an approach which would allow use of all the data on potentiation. As described in the Methods a simple model can provide an initial analysis. This model relates potentiation to activation, independent of the concentration or nature of agonist. A single parameter Z (how much the effective closing rate is decreased by a potentiating steroid) is used to describe the relationship.
The data for potentiation by 1 μ M 3α5αPOH were fit to estimate the value of Z (reduction of the closing rate). The lines shown in Figure 6 are the predicted curves for this single parameter fit and values for Z are shown in Table 4 . This analysis captures most features of the data, including the general shape of the curves and the effects of the mutations. However, the data also suggest that the model is too simple. The major deviation is that potentiation at very low activation is underestimated. This might suggest that potentiation at very low activation is more efficacious than at greater levels of activation, perhaps as a result of some dependence of steroid binding or potentiation on the state of the GABA-A receptor.
The inverse of Z is very close to the mean potentiation calculated for small responses (compare Tables 2 and 4) . This relationship makes sense, because the fractional activation for a small response is close to the ratio of the opening to the closing rates (see Methods). In this analysis potentiation is postulated to result from a decrease in the closing rate, and so it would be predicted that potentiation would increase the response by 1/Z-fold. Overall, this analysis This article has not been copyedited and formatted. The final version may differ from this version. 
Relationship between potentiation and [3α5αPOH]
We performed a preliminary study of the relationship between potentiation and (Akk et al., 2004) , and the EC 50 for the macroscopic gating curve for GABA is shifted to lower concentration. Accordingly, it seemed possible that the effects on steroid potentiation and GABA activation are mechanistically related and that tryptophan at position 241 might mimic a bound steroid agonist whereas leucine might mimic an inverse agonist. However, it is unlikely that leucine acts as an inverse agonist. The first reason is that Q241S and Q241T also shift the EC 50 for GABA activation to the same extent as Q241L but do not remove potentiation (Hosie et al., 2006) . The second is that one steroid analogue is able to potentiate receptors which contain the α 1 Q241L mutation (Akk et al., 2008) . Accordingly, it seems that mutations to α 1 Q241 can have separable effects on activation by GABA and potentiation by steroids. The possibility that the Q241W mutation acts as a (partial) steroid mimic will be considered further, below.
When the α 1 Q241L mutation is in the γ β α concatemer there is a minimal effect on the EC 50 for GABA, whereas the mutation in the β α concatemer produces an increase, and the mutation in both concatemers a greater increase. The presence of the Q241W mutation in either single concatemer produces a reduction in the EC 50 , although the mutation in the β α concatemer produces a larger effect. One interpretation is that the Q241W mutation does mimic, at least in some respects, the presence of a bound steroid potentiator. We have found that a steroid can potentiate even when only one site is intact, so the change in GABA potency may reflect the gating changes produced by mimicry of one or two steroid molecules bound to the receptor. In the case of the Q241L mutation it may be that the difference in the changes in This article has not been copyedited and formatted. The final version may differ from this version. We tested responses to a single, high concentration of P4S to estimate the potency of P4S compared to GABA. The α 1 Q241L mutation resulted in non-significant decreases in the relative response to 1 mM P4S. Based on previous studies, we had expected that the Q241W mutation would increase the relative efficacy for P4S. This expectation was confirmed. Again, when a single subunit is mutated a partial effect results.
Effects of mutations on potentiation by steroids
Either α 1 mutation essentially removed potentiation when present in both concatemers.
We tested both a 5α-and a 5β-reduced steroid for potentiation of responses to low concentrations of GABA, as these steroids differ in terms of the planarity of the steroid core ring system ( Figure 1 ). However, no major difference is seen between the effects of selective maximal concentration of P4S. However, the mutation has a major effect to enhance the relative efficacy of P4S. If both effects result from the mutation mimicking a bound steroid, then it might be expected that they would be multiplicative: the enhancement of potency would occlude the increase due to potentiation and the overall activation as a fraction of maximal response would be constant. This expectation is qualitatively correct (see Table 5 ). These results clearly distinguish the consequences of the two mutations, as the Q241L mutation reduces the potentiated response, and are consistent with the idea that the α 1 Q241W mutation does mimic a bound steroid.
Overall effects of mutations in individual α
subunits
The major point is that neither mutation in a single and 5β-reduced steroids. Hence, either site can mediate at least partial potentiation. However, the removal of a single site cannot produce the effects of mutating both sites, indicating that both sites are involved in producing the full effects on a wild-type receptor.
A second general point is that the effect of a single mutation appears to be greater when the mutation is present in the β α concatemer than the γ β α . The differences do not reach statistical significance, but for a total of 11 comparisons the effect of a mutation in the γ β α concatemer is less than that of a mutation in the β α concatemer for every assay. The likelihood that this would occur by chance is less than 0.0005 (that is, 0.5 11 , with the null hypothesis that the effects are equal and any difference is random). However, the reason for the trend is not clear. It might be that there are subtle differences between the two sites in terms of steroid
interactions. An alternative, however, is that the difference arises from the properties of the adjacent β subunits and interactions among subunits. In the assembled receptor, the both sides. We have already argued that the shift in the GABA EC 50 produced by the Q241L mutation is likely an independent action from the reduction in steroid potentiation. The observation that this effect shows the same positional sensitivity might support this interpretation that intersubunit interactions underlie the differences. It has also been reported that the two β subunits are not identical in terms of agonist-binding and receptor activation (Baumann et al., 2003) . Further experiments will be required to examine coupling to agonist binding and receptor activation, and overall interactions among adjacent subunits.
The observations with the two mutations are complementary. The α 1 Q241L mutation appears to prevent effective interaction between the receptor and the steroid, whereas the Q241W mutation appears to mimic a steroid. In either case, mutation of the site in the β α concatemer produced stronger effects than the mutations in the γ β α concatemer.
Inspection of Figure 8 shows a pattern for the effects of the Q241L mutation -the effect when the mutation is present in both concatemers is larger than the sum of the effects for each concatemer separately. Indeed, this is the case for all six assays, in contrast to the results for the Q241W mutation. If the mutations in the two α subunits contribute independently to the overall function of the receptor, then the logarithms of the effect ratios should add. This is based on the idea that the energetic contributions to the overall functional equilibrium would sum if the mutations had independent effects. The difference in effect between the double mutation and the sum of the two single mutations can be interpreted in terms of a "coupling energy" as for This article has not been copyedited and formatted. The final version may differ from this version. mutant-cycle analysis (LiCata and Ackers, 1995) . In the present work the two α subunits are widely separated, in contrast to many studies of coupling energy which have emphasized residues in close proximity, and it has been proposed that non-additivity for distant residues should be assessed using the criterion that the coupling energy be greater than 20% of the energy change for the double mutation (Istomin et al., 2008) . On this basis all assays for the Q241L mutation show non-additive effects. However, we note that all of the calculated energy changes are relatively small, with an average change of about 0.9 or 1.1 kCal/mole (absolute value) for the double mutations and 0.4 or 0.1 kCal/mole coupling energy for the Q241L or Q241W mutations, respectively. If the Q241W mutation does mimic the presence of a steroid, these results suggest that occupation of the sites makes essentially independent contributions to function. In contrast, the results for the Q241L mutation are consistent with the idea that the functional properties of the receptor result from global function and include subunit interactions.
The major conclusions from these studies are that the sites on the two Table 1 ). For easier comparison of the curves, the data have been normalized to the fit maximal amplitude for display in the Figure ( fit maximal amplitudes are shown in Table 1 ). Points show mean ± SE for 3 to 15 oocytes (small symbols in Panel A show data for single oocytes). Table 3 ). Mean potentiation ratios are shown in Table 3 . Potentiation for responses to GABA and P4S is affected essentially equivalently by the mutations. close to the effect seen when the mutation is present in both concatemers. However, this is not seen for the Q241L mutation (Panel A), for which the presence of the mutation in both concatemers leads to a larger effect than expected.
This article has not been copyedited and formatted. The final version may differ from this version. Tables   Table 1. Constructs GABA, n GABA, EC 50 ( This article has not been copyedited and formatted. The final version may differ from this version. and probability that the potentiation ratio is significantly different from 1 (that is, no effect). (--not applicable, ns P>0.05, * P < 0.05, ** P < 0.01, *** P < 0.001). (Comparisons among groups have a Dunnett correction following ANOVA to correct for multiple comparisons.) Individual value shown when only one oocyte had a control fractional response less than 0.11 (see Supplementary Figure 2 ).
This article has not been copyedited and formatted. The final version may differ from this version. Table 4 . Fit values for Z. Table 4A shows the data for potentiation of responses to low concentrations of GABA and Table 4B that (Table 2) .
This article has not been copyedited and formatted. The final version may differ from this version. Supplemental Figure 1 Traces are shown for responses of oocytes injected with the indicated constructs and stimulated with the indicated solutions. In Supplemental Figure 1A data are shown for oocytes injected with concatemers containing the α1 Q241L mutation (except for the top row, which is wild-type). In Supplemental Figure 1B data are shown for oocytes injected with concatemers containing the α1 Q241W mutation (except for the top row, which is wild-type).
Note that applications were continued until the response had reached an apparent steady-state. The kinetics of the responses reflect some variability in perfusion, location of the oocyte and other technical factors, and we have not made a systematic study. In some cases (e.g. Supplemental Figure  1A , βaL γβα) the response continues across the entire panel; in these cases when the application was terminated the current returned to baseline (data not shown).
For each row of the Figure, all responses are from the same oocyte. The responses have been normalized to allow easier comparison, with inward current shown downward. For the left-hand column, responses to 1 mM GABA, 1 mM P4S and 1 mM P4S + 1 μM 3α5αPOH are shown, normalized to the response to 1 mM GABA. For the right-hand column responses to low [GABA] , low [GABA] + 1 μM 3α5αPOH and low [GABA] + 1 μM 3α5βPOH are shown, normalized to the response to low [GABA] alone. The left-hand column illustates the effects of mutations on responses to P4S alone and potentiation of that response, whereas the right-hand column illustrates the effects of mutations on potentiation by a 5α-and a 5β-reduced steroid. The mean values for potentiation ratios from all oocytes are shown in the Tables in the paper.
The actual amplitudes of the responses for the oocytes are: βα+γβα: 1 mM GABA -2.3 μA, 30 μM GABA -0.19 μA; βα+γβαL: 1 mM GABA -10 μA; 30 μM GABA -0.33 μA; βαL+γβα: 1 mM GABA -0.85 μA, 30 μM GABA -0.04 μA; βαL+γβαL: 1 mM GABA -5.9 μA, 30 μM GABA -0.27 μA; βα+γβαW: 1 mM GABA -7.2 μA, 10 μM GABA -0.31 μA; βαW+γβα: 1 mM GABA -6.6 μA, 10 μM GABA -0.46 μA; βαW+γβαW: 1 mM GABA -31 μA, 5 μM GABA -3.8 μA; Supplemental Figure 2 Plots of potentiation ratio versus control response for all steroids tested on concatemers containing the α1 Q241L mutation.
SUPPLEMENTAL FIGURE 3
Potentiation ratio Supplemental Figure 3 Plots of potentiation ratio versus control response for all steroids tested on concatemers containing the α1 Q241W mutation.
